Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Request to Exclude Nomination Pursuant to Rule 14a-8(i)(8)

Not my proposal, but the only one from a pragmatic perspective which might get you on the BoD. One has to remember that in the event of there being more than one alternative nominee proposed under the 3% Rule, the person with most support (shares) will be included. All others can then be refused in full compliance of SEC Rules.

.

.

.

Be well

Share
New Message
Please login to post a reply